When things go bad for high-profile Wal-Mart (NYSE: WMT ) , it can get ugly. The discount retailer has hit another public relations speed bump given its guilty plea to charges of improper disposal of hazardous waste, with pollutants having gone down sanitation drains in California. The company will pay a pretty penny: an $81 million fine, which also covers related allegations in Missouri.
In its press release, Wal-Mart explained that the charges stem from activities that took place years ago, that regulators did not allege specific environmental impact, and that it now has comprehensive environmental programs in place. It gave examples of its more responsible methods for disposing of such waste after it began implementing stringent environmental measures in 2006, some of which the EPA�says go above and beyond regulatory laws.
Hazard pay and hazard payback
Regardless, the idea of costs -- both financial and reputational -- comes at an interesting time given a pending shareholder proposal. The resolution asks that Wal-Mart disclose utilization of its existing clawback policy to recoup compensation from executives that have indulged in unethical behavior or acts considered detrimental to the company. Investors will vote on the measure at the company's annual meeting on June 7.
5 Best Medical Stocks To Watch Right Now: Hormel Foods Corporation (HRL)
Hormel Foods Corporation processes, markets, and sells consumer-branded meat and food products. The company operates in five segments: Grocery Products, Refrigerated Foods, Jennie-O Turkey Store, Specialty Foods, and International & Other. The Grocery Products segment offers shelf-stable food products, including canned luncheon meats, shelf-stable microwaveable meals, stews, chilies, hash, meat spreads, flour and corn tortillas, salsas, and tortilla chips in the retail market. The Refrigerated Foods segment provides branded and unbranded pork and beef products for retail, foodservice, and fresh product customers. The Jennie-O Turkey Store segment offers branded and unbranded turkey products for retail, foodservice, and fresh product customers. The Specialty Foods segment is involved in the packaging and sale of various sugar and sugar substitute products, salt and pepper products, liquid portion products, dessert mixes, ready-to-drink products, sports nutrition products, g elatin products, and private label canned meats to retail and foodservice customers. This segment also processes, markets, and sells nutritional food products and supplements to hospitals, nursing homes, and other marketers of nutritional products. The International and Other segment manufactures, markets, and sells its products internationally. Hormel Foods Corporation sells its products through sales personnel, as well as through independent brokers and distributors primarily in the United States, Australia, Canada, China, England, Japan, Mexico, Micronesia, the Philippines, and South Korea. The company was formerly known as George A. Hormel & Company and changed its name to Hormel Foods Corporation in January 1995. Hormel Foods Corporation was founded in 1891 and is based in Austin, Minnesota.
Advisors' Opinion:- [By Jonathan Yates]
Based in Minnesota, C.H. Robinson Worldwide offers global transportation services. It�is one of the largest holdings of Mairs & Power Growth, an excellent mutual fund that has a fondness for companies in Minnesota. Others include Hormel (NYSE: HRL) and 3M (NYSE: MMM). That is fine company for a medium cap like C.H. Robinson Worldwide to be associated with.
10 Best High Tech Stocks To Buy Right Now: Rally Software Development Corp (RALY)
Rally Software Development Corp., incorporated on July 12, 2001, is a global provider of cloud-based solutions for managing Agile software development. The Company's platform transforms the way organizations manage the software development lifecycle by enabling close alignment of software development and strategic business objectives, facilitating collaboration, increasing transparency, and automating manual processes. Organizations use its solutions to accelerate the pace of innovation, improve productivity and more effectively adapt to rapidly-changing customer needs and competitive dynamics. Its enterprise-class platform is extensible, cost-effective and designed to be easy to use. Agile is a software development methodology characterized by short, iterative and adaptable development cycles.
The Company provides a common platform on which organizations can collaborate across globally-distributed software development teams, solicit ideas and feedback from customers, and gain transparency into Agile software development projects. Its solutions automate and optimize activities such as project planning and scheduling, resource allocation and reporting on progress and cost, enabling users to manage the entire Agile software development lifecycle. Its cloud-based platform of management solutions is designed to address the application lifecycle market, which IDC defines as comprising the software configuration management, information technology (IT) project and portfolio management, and automated software markets.
Agile Management Solutions
It offers Agile management solutions that its customers use for planning, collaborating, tracking and reporting on the creation of new software products and applications. Its solutions support the full software development lifecycle with key capabilities that include Idea Management, Agile Portfolio Management, Time and Cost Management, Agile Project Management, Requirements Management and Quality Management. Its Idea Management c! apability, Rally Idea Manager, is used by its customers to engage with their end users to solicit ideas for products and manage feedback on proposed features and enhancements. This capability establishes a communication channel between its customers and their end-users. Teams and organizations use this capability to engage directly with end-users in an online community, collect information to assess customer needs and automatically communicate development status to end-users.
Its Agile Portfolio Management capability, Rally Portfolio Manager, bridges the gap between business leaders and development teams. Business leaders are provided up-to-date and accurate information on the status of key projects while development teams are provided clear visibility into the priorities of the business in order to better align their feature backlogs. Our Time and Cost Management capability, Rally Time Tracker, enables key financial functions related to software development, such as software capitalization, cost tracking, budget management and billing. This capability reduces double entry in other systems and ensures data is captured and aggregated into reports. Teams and organizations use this capability to reduce daily overhead of tracking time by integrating into the daily process, design and generate aggregate timesheets to meet accounting, budgeting or billing requirements , ensure that time entries meet audit and compliance requirements and integrate time tracking information into existing back office and time and attendance applications.
Its Agile Project Management capability allows cross-functional teams to efficiently plan and manage software releases. Teams and organizations use this capability to manage product and release backlogs that reflect the priorities of the business, schedule all or parts of requirements from backlogs into releases based on capacity and real-time visibility into the status of features, priorities, roadblocks and risks. Its Requirements Management capabil! ity enabl! es business leaders and analysts to centrally manage and prioritize features for development. Users can elaborate requirements with needed details, break them up into smaller units and organize them to match the changing structures of their teams or technology components. Its Quality Management capability, Rally Quality Manager, enables testing engineers to integrate testing into the development process from the beginning of a project. This capability provides a full enterprise solution to plan and track the execution of test activities.
Platform Capabilities
Its platform employs a analytics and reporting engine. In addition to over 25 pre-built standard reports, its platform includes a custom reporting engine that allows customers to create reports to meet their needs. Its platform also includes dashboard technology to present personalized content and then share that content for consistent use across a team or organization. Its platform provides enterprise-class security capabilities simplifying the administration of thousands of users. It can integrate its platform with its customers' existing security infrastructure to provide end-users with the ability to have single-sign-on (SSO) and provide advanced security measures to reduce risk and meet the needs of enterprises. This adaptability also ensures its solutions can be configured to meet the changing needs of an organization. It offers an open Web services application programming interface (WSAPI) providing full read-write access to all of the data within its platform. The WSAPI is versioned so that integrations or customizations are insulated from changes in the WSAPI, thereby preserving a customer's investment in custom functionality.
It provides customization services that produce Apps for specific customer needs. Examples of Apps that are available in its catalog include Dependency Status Dashboard enables organizations to view dependencies between teams and forecast potential impediments and stoppages in ! a project! ; System Requirement Validation Document generates a document for signature and archival typically used by customers in regulated industries to validate that the requirements of a system or application have been met; Agile Earned-Value Management provides a report based on traditional project management practices that provides what-if scenarios for planning scope, schedule and budget, and There are over 40 integrations available for its platform. It has 25 pre-built integrations with complementary products that synchronize their data with its platform. Additionally, there are over 20 integrations that third parties have created with its platform that they offer to their customers. It also integrates with open-source development tools, including Subversion, Jenkins and Eclipse, as well as commercial products, including Microsoft Excel, Microsoft Visual Studio and HP QualityCenter.
Editions
It offers four editions of its Agile management solution. Each edition is built on the same software code base. Rally Community Edition is designed for an individual team that operates independently, even if it is part of a larger organization. Community Edition includes a basic version of Agile Project Management and Requirements Management capabilities and is available for free for 10 users and one project.
Rally eXpress Edition is designed for both and small organizations and scales from a single team to multiple, independent teams and projects. eXpress Edition includes a basic version of Agile Project Management and Requirements Management capabilities. eXpress Edition supports unlimited users and projects.
Rally Enterprise Edition is targeted at medium to organizations focused on coordinating projects across multiple teams. Enterprise Edition includes Agile Project Management, Requirements Management and basic Quality Management capabilities. Enterprise Edition supports unlimited users and projects.
Rally Unlimited Edition is built for organizations and ! offers it! s full set of capabilities for managing the entire software lifecycle, including Idea Management, Agile Portfolio Management, Time and Cost Management, Agile Project Management, Requirements Management and Quality Management. Unlimited Edition supports unlimited users and projects.
On-Premise Deployment Option
A small percentage of its customers deploy its solutions on-premise. When its software is installed at the customer site, it specifies the hardware requirements and deliver its solutions on a virtual software appliance.
Professional Services
It offers a broad array of professional services to its customers to assist them in the implementation of its platform and adoption of Agile techniques.It offers its services globally. It offer public and private courses educating customers on Agile practices. A number of its training courses are certified by the independent organization Scrum Alliance. Through its Agile University brand, it offers Agile-related education and coursework taught by its consultants and a network of instructors. It offers a broad set of services that help customers implement Agile practices across their organization. It aims to make organizations self-sufficient so they can continue expanding their usage of Agile after it concludes its services engagement. Its implementation services combine workshops and training to help organizations incorporate its platform into their development process. These services include process training and product customization to help organizations take advantage of the full breadth of capabilities its platform offers. Customers can elect to leverage its platform extension services to customize its platform to meet the specific needs of their organization. It creates custom Apps and customized integrations to ensure that its solutions fit a customer's infrastructure and practices, and it offers data migration services to migrate data from a customer's legacy application into its platform.
The ! Company competes with Atlassian, CollabNet, VersionOne, Hewlett-Packard, IBM and Microsoft.
Advisors' Opinion:- [By Evan Niu, CFA]
What: Shares of Rally Software (NYSE: RALY ) rallied today by as much as 20% after the company announced fiscal first quarter results.
- [By John Udovich]
Small cap cloud and enterprise services stock Rally Software Development Corp (NYSE: RALY) just had a reversal ��meaning its worth taking a closer look at the stock along with potential performance benchmarks like Oracle Corporation (NYSE: ORCL), iShares North American Tech-Software (NYSEARCA: IGV) and First Trust ISE Cloud Computing Index (NASDAQ: SKYY).
10 Best High Tech Stocks To Buy Right Now: Brookfield Office Properties Inc. (BPO)
Brookfield Properties Corporation is a publicly owned real estate investment firm. The firm engages in the ownership, development, and management of premier commercial properties. It also provides ancillary real estate service businesses, such as tenant service and amenities. The firm invests in the real estate markets of the United States with a focus on North American cities, including New York, Boston, Washington, D.C., Toronto, Calgary, Denver, and Minneapolis. It primarily invests in properties and development sites predominantly office buildings. The firm operates as a subsidiary of Brookfield Asset Management Inc. It was formerly known as Carena-Bancorp Holdings, Inc. and changed its name to Le Holding Carena-Bancorp Inc. in 1978. The company further changed its name to Carena-Bancorp, Inc. in 1985; to Carena Developments Limited in 1989; and to Brookfield Properties Corporation in 1996. Brookfield Properties was founded in 1923 and is based in New York, New York wi th an additional office in Toronto, Canada
Advisors' Opinion:- [By gurujx]
Brookfield Office Properties Inc (BPO) Reached the 52-Week High of $20.52
Brookfield Office Properties Inc. was formed under the Canada Business Corporations Act on September 5, 1978 to continue the business of Canadian Arena Corporation which was incorporated in 1923 under the Quebec Companies Act, 1920. Brookfield Office Properties Inc has a market cap of $10.41 billion; its shares were traded at around $20.52 with a P/E ratio of 19.50 and P/S ratio of 4.56. The dividend yield of Brookfield Office Properties Inc stocks is 2.73%. Brookfield Office Properties Inc had an annual average earnings growth of 16.70% over the past 10 years.
- [By Luke Jacobi]
Brookfield Office Properties (NYSE: BPO) got a boost, closing up 13.71 percent to $19.07 after Brookfield Property Partners (NYSE: BPY) proposed to acquire Brookfield Office Properties for $19.34 per share.
- [By Victor Selva]
Xerox Corporation (XRX), with a market capitalization of $13.11 billion, is among the largest companies in the global document markets. It is a provider of business process and document management. The company is a Business Process Outsourcing (BPO) company engaged in managing transaction processes.
10 Best High Tech Stocks To Buy Right Now: Impax Laboratories Inc.(IPXL)
Impax Laboratories, Inc., a specialty pharmaceutical company, engages in the development, manufacture, and marketing of bioequivalent pharmaceutical products. The company operates in two divisions, Global Pharmaceuticals and Impax Pharmaceuticals. The Global Pharmaceuticals division develops, manufactures, sells, and distributes generic pharmaceutical products. It provides its generic pharmaceutical prescription products directly to wholesalers and retail drug chains; and generic pharmaceutical over-the-counter and prescription products through unrelated third-party pharmaceutical entities. The Impax Pharmaceutical division develops proprietary brand pharmaceutical products that address central nervous system disorders, including Alzheimer?s disease, attention deficit hyperactivity disorder, depression, epilepsy, migraines, multiple sclerosis, Parkinson?s disease, and schizophrenia, as well as promotes third-party branded pharmaceutical products. As of May 2, 2011, the com pany marketed 101 generic pharmaceuticals, which represent dosage variations of 29 different pharmaceutical compounds; and another 16 of its generic pharmaceuticals representing dosage variations of 4 different pharmaceutical compounds. It markets and sells its generic pharmaceutical prescription drug products in the continental United States and the Commonwealth of Puerto Rico. The company has a strategic alliance agreement with Teva Pharmaceuticals Curacao N.V. Impax Laboratories, Inc. was founded in 1993 and is headquartered in Hayward, California.
Advisors' Opinion:- [By Garrett Cook]
Shares of Impax Laboratories (NASDAQ: IPXL) were down 12.81 percent to $24.44 after the FDA issued a Form 483 with 10 inspectional observations for Impax Taiwan plant.
- [By Keith Speights]
Impax Laboratories (NASDAQ: IPXL ) could be watching more closely than Sanofi. The two companies reached a deal last year that allows Impax to begin marketing a generic version of Renvela in 2014. If approved, Zerenex could take away some of the profits that Impax expected to gain.�
- [By Eric Volkman]
Impax Laboratories (NASDAQ: IPXL ) �will soon hand out a raft of pink slips. As part of a move to slice costs, the company has announced a reduction in its headcount by roughly 110 employees. Most of these cuts will be effected at its manufacturing facility in Hayward, Calif.
- [By Max Macaluso, Ph.D.]
RLS hasn't been a high-priority target for the pharma industry given the lackluster sales of Requip and Horizant, a third competitor of�UCB's Neupro, and a number of generic alternatives. Impax Laboratories (NASDAQ: IPXL ) was one of the few developing a new therapy, called IPX159, but Impax put the kibosh on the drug after it failed to meet its primary endpoint in a phase 2b study. According to its latest quarterly report, Impax has no other RLS drugs in development and seems to be focusing on getting its rejected Parkinson's disease drug Rytary back to the FDA for a second chance at approval.
10 Best High Tech Stocks To Buy Right Now: USG Corporation(USG)
USG Corporation, through its subsidiaries, engages in the manufacture and distribution of building materials worldwide. The company offers gypsum and related products, including gypsum wallboard, joint compounds used for finishing wallboard joints, cement boards, glass mat sheathing, gypsum fiber panels, poured gypsum underlayments, ultra light panels, and various construction plaster products. Its gypsum products are used in various building applications to finish the interior walls, ceilings, and floors in residential, commercial, and institutional constructions, and repair and remodel constructions. The company also produces gypsum-based products for agricultural and industrial customers to use in various applications, including soil conditioning, road repair, fireproofing, and ceramics. In addition, it manufactures ceiling grid and acoustical ceiling tile for electrical and mechanical systems, and air distribution and maintenance applications. USG Corporation distribut es its gypsum products through specialty wallboard distributors, building materials dealers, home improvement centers and other retailers, contractors, and a network of distributors. Further, it distributes other manufacturers? gypsum wallboard, joint compound and other gypsum products, as well as drywall metal, insulation, and roofing products and accessories. The company sells its products under SHEETROCK, DUROCK, FIBEROCK, SECUROCK, LEVELROCK, RED TOP, IMPERIAL, DIAMOND, SUPREMO, AURATONE, ACOUSTONE, DONN, DX, FINELINE, CENTRICITEE, CURVATURA, and COMPASSO brands. The company was founded in 1901 and is based in Chicago, Illinois.
Advisors' Opinion:- [By Matt Jarzemsky]
While economists attributed some of the downtick to cold and snowy weather, some are wondering if the Federal Reserve�� plan to dial back its stimulus program this year could lead to a rise in interest rates, putting the brakes on the housing recovery. The SPDR S&P Homebuilders exchange-traded fund��hich tracks a broad basket of housing-related stocks from builders to Sheetrock maker USG Corp.(USG)��s down about 3.6% year-to-date.
- [By Holly LaFon]
Pimco managing director Mark Kiesel mentions Whirlpool (WHR), Weyerhaeuser (WY), USG (USG), Toll Brothers (TOLL) and KB Home (KBH) as good plays on housing:�
- [By Eric Volkman]
She also serves as chairman of the United States Steel and Carnegie Pension Fund, and on that organization's investment committee. Outside of U.S. Steel, she sits on the board of directors of USG (NYSE: USG ) and the Pennsylvania Business Council, among other entities.
- [By Seth Jayson]
USG (NYSE: USG ) reported earnings on April 24. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended March 31 (Q1), USG missed estimates on revenues and missed estimates on earnings per share.
10 Best High Tech Stocks To Buy Right Now: COCA COLA HELLENIC BOTTLING CO (CCH)
Coca-Cola HBC AG operates as a bottler of products of The Coca-Cola Company in Switzerland and internationally. It offers a range of ready-to-drink non-alcoholic beverages in the sparkling, juice, water, sport, energy, tea, and coffee categories. The company has operations in 28 countries serving approximately 581 million people. Coca-Cola HBC AG is based in Zug, Switzerland. As of April 22, 2013, Coca-Cola HBC AG operates as a subsidiary of Kar-Tess Holding S.A.
Advisors' Opinion:- [By Ben Levisohn]
Berkshire’s ownership position in�Coca-Cola may set the stage for something similar to Duracell��ith Berkshire’s 400 million�Coca-Cola shares currently worth $17.8 billion, and an estimated value for CCR (Coca-Cola’s North American bottling assets) of $12.8 billion (based on 8x estimated EBITDA of $1.6 billion), this would not be a large enough transaction for Berkshire to completely transfer its�Coca-Cola stake. Of course, we do not think�Coca-Cola needs to capitalize the business with $5 billion in cash, as Procter & Gamble did for Duracell to “plug the gap” between the valuation of the business and Berkshire’s stake, but that may be a possibility in this instance as well. However��all us crazy��e think Berkshire could also take a look at CCEAG, Coca-Cola’s German bottling business. We valued this at $2.75 billion three years ago6, based on $3.8b of revenue, a 10.4% EBITDA margin and a 7.0x multiple. We think there is upward bias to a current valuation given likely cost rationalization that has occurred in the intervening years. If we wanted to get even more creative, we could even envision Berkshire taking a look more broadly at European bottlers like Coca-Cola Enterprises (CCE) and Coca-Cola HBC (CCH), which have similar industry dynamics to the U.S. bottlers. We note that some type of swap transaction, � la Duracell, could save Berkshire Hathaway nearly $5 billion in income taxes.
10 Best High Tech Stocks To Buy Right Now: Antares Pharma Inc (ATRS)
Antares Pharma, Inc. (Antares) is a pharma company that focuses on self-injection pharmaceutical products and technologies and topical gel-based products. The Company�� subcutaneous and intramuscular injection technology platforms include Vibex disposable pressure-assisted auto injectors, Vision reusable needle-free injectors, and disposable multi-use pen injectors. In the injector area, it has licensed its reusable needle-free injection device for use with human growth hormone (hGH) to Teva, Ferring Pharmaceuticals BV (Ferring) and JCR Pharmaceuticals Co., Ltd. (JCR), with Teva and Ferring being its two primary customers. The Company has also licensed both disposable auto and pen injection devices to Teva for use in certain fields and territories and is engaged in product development activities for Teva utilizing these devices.
In the gel-based area, it received Food and Drug Administration (FDA) approval in December 2011 for its oxybutynin gel 3% product, Anturol, for the treatment of overactive bladder. Antares also has a licensing agreement with Watson Watson Pharmaceuticals, Inc. (Watson) under which Watson will commercialize its topical oxybutynin gel 3% product in the United States and Canada. Its gel portfolio also includes Elestrin (estradiol gel) in the United States for the treatment of moderate-to-severe vasomotor symptoms associated with menopause. Antares has designed disposable, pressure assisted auto injector devices to address acute medical needs, such as allergic reactions, migraine headaches, acute pain, emesis and other daily therapies.
Pressure Assisted Injection Devices
The Company�� Pressure Assisted Injection Devices consists of three products: reusable needle-free injectors, disposable pressure assisted auto injectors and disposable pen injectors. Reusable needle-free injectors deliver precise medication doses through high-speed, pressurized liquid penetration of the skin without a needle. The injector employs a disposable pl! astic needle-free syringe, which offers liquid medication delivery through an opening that is approximately half the diameter of a standard, 30-gauge needle.
Disposable pressure assisted auto injectors is a technology of controlled pressure delivery of drugs into the body utilizing a spring power source. The Vibex is designed to provide fast subcutaneous or intramuscular injections of up to 0.5ml with minimal discomfort and improved convenience in conjunction with the enhanced safety of a shielded needle. Disposable pen injectors are needle-based devices designed to deliver multiple injections from multi-dose drug cartridges. The devices contain mechanisms that specify the dose to be delivered by defining the amount of movement by the stopper in the cartridge with each device actuation.
The Vision/Tjet has been sold for use in more than 30 countries to deliver either insulin or hGH. The product features a reusable, spring-based power source and disposable needle-free syringe, which acts as the pathway for the injectable drug through the skin and allows for viewing of the medication dose prior to injection. The product is also reusable, with each device designed to last for approximately 3,000 injections (or approximately two years) while the needle-free syringe, when used with insulin or hGH, is disposable after approximately one week when used by a single patient for injecting from multi-dose vials. The Vision/Tjet administers injectables by using a spring to push the active ingredient in solution or suspension through a micro-fine opening in the needle-free syringe. The opening is approximately half the diameter of a 30-gauge needle. The Vision/Tjet is primarily used in the United States, Europe, Asia and Japan.
Antares has designed disposable, pressure assisted auto injector devices to address acute medical needs, such as allergic reactions, migraine headaches, acute pain, emesis and other daily therapies. Its Vibex disposable product combines a low-energy, spr! ing-based! power source with a hidden needle, which delivers up to 0.5ml of the needed drug solution subcutaneously or intramuscularly. Antares is also developing a Vibex MTX auto injector for delivery of methotrexate for treatment of rheumatoid arthritis. The Company�� multi use, disposable pen injector complements its portfolio of single-use pressure assisted auto injector devices. The disposable pen injector device is designed to deliver drugs by injection through needles from multi- dose cartridges. The disposable pen is in the stage of development where devices are being used in clinical evaluations.
Transdermal Products
The Company�� ATD system penetrates the skin to deliver a variety of treatments. The gels consist of a hydro-alcoholic base, including a combination of permeation enhancers. Products being developed/ commercialized include Anturol, Elestrin and Nestragel. Elestrin is a transdermal estradiol gel for the treatment of moderate-to-severe vasomotor symptoms associated with menopause. Its other injectable drugs that are presently self-administered and may be suitable for injection with its systems include therapies for the prevention of blood clots and treatments for multiple sclerosis, migraine headaches, inflammatory diseases, impotence, infertility, acquired immune deficiency symdrome (AIDS) and hepatitis.
The Company competes with Ypsomed AG, SHL Group AB, OwenMumford Ltd., West Pharmaceuticals, Becton Dickinson, Haselmeir GmbH, Elcam Medical, Vetter Pharma, Bioject Medical Technologies Inc., The Medical House PLC, Watson, Abbott, Eli Lilly, Auxillium, Inc., Endo Pharmaceuticals, Teva, Mylan, Roxane, Bedford Labs, APP Pharmaceuticals, Hospira, Pfizer, GSK/Astellas, Warner Chilcott and Allergan.
Advisors' Opinion:- [By Keith Speights]
1. Antares Pharma (NASDAQ: ATRS )
Antares has experienced a roller-coaster ride so far this year. The stock was up more than 10% early in January, then proceeded to fall by more than 20% by late February. Since then, Antares has clawed its way back and now stands up a little over 10% for the year.�
No comments:
Post a Comment